TP53 and non-small cell lung carcinoma: Some previous studies investigated the association between RFS of early‐stage NSCLC and hotspot mutation of KRAS and/or TP53 obtained by resected tumor or noncancerous tissue located near resected tumor,23, 24 but the results were not necessarily in agreement.